George Mason University
The Institute for Biohealth Innovation (IBI) at George Mason University unites over 300 faculty and thousands of students across 34 departments to advance human health and well-being through innovative research. The IBI focuses on major health challenges, including infectious diseases, cancer, brain and behavior, and cardiovascular health, collaborating with national and international partners to implement solutions that enhance health outcomes.
Industries
N/A
Nr. of Employees
small (1-50)
George Mason University
Institute for Biohealth Innovation, George Mason University, 4400 University Drive, Fairfax, VA 22030
Patents
Method of determining risk for skin cancer development and skin cancer therapeutic prevention by measuring PD-1/PD-L1 signaling pathway members
US-12516382-B2
View DetailsFederated graph neural network for fast anomaly detection in controller area networks
US-12488049-B2
View DetailsSystems and methods for gait-based user authentication for lightweight resource-constrained wearable devices
US-12468794-B2
View DetailsMembrane coverage and orientation and methods, compositions, and kits related thereto
US-12460181-B2
View DetailsAntimicrobial peptides and compositions, methods, articles and kits relating thereto
US-12384821-B2
View Details
Method of determining risk for skin cancer development and skin cancer therapeutic prevention by measuring PD-1/PD-L1 signaling pathway members
US-12516382-B2
View DetailsFederated graph neural network for fast anomaly detection in controller area networks
US-12488049-B2
View DetailsSystems and methods for gait-based user authentication for lightweight resource-constrained wearable devices
US-12468794-B2
View DetailsMembrane coverage and orientation and methods, compositions, and kits related thereto
US-12460181-B2
View DetailsAntimicrobial peptides and compositions, methods, articles and kits relating thereto
US-12384821-B2
View DetailsProducts
IBI annual and facility brochures
Published institutional reports and brochures describing institute capabilities, regional innovation park offerings, and regional lab brochures (e.g., annual report, innovation park brochure, biocontainment lab brochure).
IBI annual and facility brochures
Published institutional reports and brochures describing institute capabilities, regional innovation park offerings, and regional lab brochures (e.g., annual report, innovation park brochure, biocontainment lab brochure).
Services
On-site 3T MRI scanning for research projects with coil and sequence support and MR-compatible EEG acquisition; operation by certified technologists.
CAP/CLIA-aligned proteomics services including high-throughput protein arraying, immunohistochemistry, and immunoassay testing for biomarker verification and diagnostic assay work.
Analytical mass spectrometry services for identification and quantitation of proteins, peptides, and small molecules using multiple mass spec platforms and chromatography systems.
Sequencing and PCR services including platforms for targeted and high-throughput runs, plus on-site bioinformatics and computational support for sequence analysis.
Comprehensive metabolite profiling using GC-MS, LC-QToF MS/MS, HPLC systems and analysis software for volatile and non-volatile metabolites.
Histology embedding and sectioning, laser capture microdissection to isolate cell populations, cytospin, and magnetic cell separation for downstream molecular analysis.
On-site 3T MRI scanning for research projects with coil and sequence support and MR-compatible EEG acquisition; operation by certified technologists.
CAP/CLIA-aligned proteomics services including high-throughput protein arraying, immunohistochemistry, and immunoassay testing for biomarker verification and diagnostic assay work.
Analytical mass spectrometry services for identification and quantitation of proteins, peptides, and small molecules using multiple mass spec platforms and chromatography systems.
Sequencing and PCR services including platforms for targeted and high-throughput runs, plus on-site bioinformatics and computational support for sequence analysis.
Comprehensive metabolite profiling using GC-MS, LC-QToF MS/MS, HPLC systems and analysis software for volatile and non-volatile metabolites.
Histology embedding and sectioning, laser capture microdissection to isolate cell populations, cytospin, and magnetic cell separation for downstream molecular analysis.
Expertise Areas
- Imaging and neuroimaging
- Proteomics and biomarker development
- Mass spectrometry and analytical chemistry
- Genomics and microbiome analysis
Key Technologies
- 3T magnetic resonance imaging (MRI)
- MR-compatible EEG
- Confocal microscopy
- Protein microarrays
News & Updates
An event hosted by the Northern Virginia BioHub for networking among biotech professionals.
Talk by Dr. Gabriel Parra on Norovirus research.
Highlighting the experience of a bioengineering student at NIH.
Research on the impact of nano roughness on medical devices.
An event hosted by the Northern Virginia BioHub for networking among biotech professionals.
Talk by Dr. Gabriel Parra on Norovirus research.
Highlighting the experience of a bioengineering student at NIH.
Research on the impact of nano roughness on medical devices.